Search

Author/Creator Schecter, Robyn

1. Real-life effectiveness and tolerability of the rivastigmine transdermal patch in patients with mild-to-moderate Alzheimer's disease: the EMBRACE study. (23rd May 2013)

Authors:
Gauthier, Serge; Robillard, Alain; Cohen, Sharon; Black, Sandra; Sampalis, John; Colizza, Diane; de Takacsy, Frederica; Schecter, Robyn
Journal:
Current medical research and opinion
Issue:
Volume 29:Number 8(2013:Aug.)
Page Start:
989
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Sequencing of disease-modifying therapies for relapsing–remitting multiple sclerosis: a theoretical approach to optimizing treatment. (3rd August 2018)

Authors:
Grand'Maison, Francois; Yeung, Michael; Morrow, Sarah A.; Lee, Liesly; Emond, Francois; Ward, Brian J.; Laneuville, Pierre; Schecter, Robyn
Journal:
Current medical research and opinion
Issue:
Volume 34:Number 8(2018)
Page Start:
1419
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Cost-effectiveness of fingolimod versus interferon-β1a for the treatment of pediatric-onset multiple sclerosis in Canada. (1st December 2020)

Authors:
Nakhaipour, Hamid Reza; Vudumula, Umakanth; Khurana, Vivek; Sébire, Guillaume; Mah, Jean K.; Pohl, Daniela; Schecter, Robyn; Adlard, Nicholas
Journal:
Journal of medical economics
Issue:
Volume 23:Number 12(2021)
Page Start:
1525
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗